📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer. (2022)

First Author: Henderson RH

Attributed to: MICA: Stratification in COloRectal cancer: from biology to Treatment prediction: S-CORT funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jcpo.2022.100342

PubMed Identifier: 35718327

Publication URI: http://europepmc.org/abstract/MED/35718327

Type: Journal Article/Review

Volume: 33

Parent Publication: Journal of cancer policy

ISSN: 2213-5383